VERTEX PHARMACEUTICALS INC / MA (VRTX) scores 66 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 306.77, representing a 31% premium to fair value. Quantitative score: 65/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.